India to spend 100 billion rupees to make biopharma production hub
The funding will be directed towards the research and production of biologics and biosimilar medicines India will invest 100 billion rupees (S$1.4 billion) in biopharmaceutical…
Tag
The funding will be directed towards the research and production of biologics and biosimilar medicines India will invest 100 billion rupees (S$1.4 billion) in biopharmaceutical…
Singapore-based speciality pharmaceutical and nutraceutical company iX Biopharma raised gross proceeds of S$6.7 million in a placement to raise funds for its expansion into the US. The…
Shares of Singapore-based speciality pharmaceutical and nutraceutical company iX Biopharma jumped 35.1 per cent to S$0.127 on Monday (Oct 27). This was after it revealed early-stage plans…
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck by a…
Patients are flocking to the region in search of good quality, alternative healthcare treatments, while biopharma firms are making forays into new, emerging markets Within the Chinese…